News
Treating psoriasis with biologic drugs can reduce the early plaque buildup that clogs arteries, restricts blood flow, an…
Menlo Therapeutics Inc., a late-stage biopharmaceutical company focused on the development of serlopitant for the treatm…
Impoyz Cream (clobetasol propionate) Cream, 0.025% demonstrated efficacy early with 14.2 percent of Impoyz patients achi…
Novartis shared results from a pooled analysis of four Phase 3 clinical trials demonstrating patients with moderate to s…
Alan Menter, MD, has been awarded the Outstanding Researcher and Educator in Psoriatic Disease Award by the ODAC Dermato…
Bristol-Myers Squibb Company will acquire Celgene Corp. in a cash and stock transaction with an equity value of approxim…
In part 2 of her interview with DermTube Journal Club host Joshua Zeichner, MD, Erin Boh, MD reviews new biologics that …
Erin Boh, MD, Joshua Zeichner, MD, FAAD
Dermatologists are interested in learning more about cannabinoids and recommending them to patients, according to a new …
Treating Moderate to Severe Psoriasis: Weighing the Treatmen…